中文版 | English

在结果中检索

CASIA OpenIR
（本次检索基于用户作品认领结果）

浏览/检索结果: 共5条，第1-5条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma 期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2022, 卷号: 151, 期号: 3, 页码: 450-462
作者:  Tian, Yu;  Tang, Chu;  Shi, Guangyuan;  Wang, Guorong;  Du, Yang;  Tian, Jie;  Zhang, Haizhong
收藏  |  浏览/下载：259/0  |  提交时间：2022/07/25
fluorescence molecular imaging  glucose transporter type 1  image-guided surgery  mouth neoplasms  WZB117  
ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in Tumor Microenvironment 期刊论文
CANCERS, 2021, 卷号: 13, 期号: 7, 页码: 21
作者:  Bian, Chang;  Wang, Yu;  Lu, Zhihao;  An, Yu;  Wang, Hanfan;  Kong, Lingxin;  Du, Yang;  Tian, Jie
Adobe PDF(14076Kb)  |  收藏  |  浏览/下载：314/27  |  提交时间：2021/05/17
deep learning  cell distribution  biomarker  tumor gene mutation  tumor microenvironment (TME)  semi-supervised learning  hematoxylin and eosin (H&  E)  
Noninvasive Imaging for Assessment of the Efficacy of Therapeutic Agents for Hepatocellular Carcinoma 期刊论文
Molecular Imaging and Biology, 2019, 期号: 10.1007/s11307-019-01431-5, 页码: 1-14
作者:  Liang, Qian;  Kong, Lingxin;  Zhu, Xu;  Du, Yang;  Tian, Jie
浏览  |  Adobe PDF(3951Kb)  |  收藏  |  浏览/下载：359/121  |  提交时间：2020/06/03
Hepatocellular carcinoma  Molecular imaging  Preclinical drug evaluation  Clinical trial  Therapeutics  
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 15
作者:  Xiong, Kai;  Zhang, Hejun;  Du, Yang;  Tian, Jie;  Ding, Shigang
收藏  |  浏览/下载：247/0  |  提交时间：2019/12/16
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model 期刊论文
BMC CANCER, 2018, 卷号: 18, 页码: 7
作者:  Li, Yuan;  Du, Yang;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
浏览  |  Adobe PDF(4369Kb)  |  收藏  |  浏览/下载：465/197  |  提交时间：2019/02/18
PD-1  Zoledronic acid  Breast cancer  Therapy  Checkpoint inhibitior